Doctors Enroute Dr NP Veliotes 082 451 2810

1

Obesity is a one of the major but preventable global health crises that has been linked to major chronic illness and several cancers, with increased morbidity and mortality. Among the various cancers, breast, colorectal, endometrial, esophageal, pancreatic, renal, hepatic, stomach, gallbladder, ovarian, and thyroid cancer, as well as multiple myeloma and meningioma, are strongly associated with obesity. The underlying mechanism of obesity causing cancer is incompletely understood and involves adipokines, inflammation, an altered extracellular matrix, altered fatty acid metabolism, and the secretion of insulin-like growth factors and estrogen. Weight-reducing strategies in obesity-associated cancers are important interventions as a component of cancer care in reducing cancer-specific and overall mortality in cancer survivors with excess body weight. Regular exercise and diet, in conjunction with behavior therapy, are the primary elements of weight reducing strategies. More data are needed regarding the efficacy and safety of pharmacologic and surgical interventions as a major weight reduction strategy in cancer survivors.A

COVID Variant EG.5 was originally driven by circulation in China, Japan and South Korea and now, it has been increasing in North America and in Europe. In France, EG.5 represented 26 per cent of sequences on 17 July compared to 15 per cent of sequences the week prior. In the UK, EG.5.1 in particular has the highest growth rate for variants in the country and represents 14 per cent of cases. In the United States, EG.5 represents roughly 17 per cent of cases, more than any other lineage of Omicron that is being monitored, according to data from the Centres for Disease Control and Prevention (CDC)